{"id":2899,"date":"2022-05-27T11:10:40","date_gmt":"2022-05-27T10:10:40","guid":{"rendered":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial.png"},"modified":"2022-05-27T11:10:40","modified_gmt":"2022-05-27T10:10:40","slug":"2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-2","status":"inherit","type":"attachment","link":"https:\/\/bibliography.nanobiotix.com\/fr\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial__trashed\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-2\/","title":{"rendered":"2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial"},"author":1,"comment_status":"open","ping_status":"closed","template":"","meta":[],"aioseo_notices":[],"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial.png'><img width=\"223\" height=\"300\" src=\"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-223x300.png\" class=\"attachment-medium size-medium\" alt=\"\" decoding=\"async\" loading=\"lazy\" srcset=\"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-223x300.png 223w, https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-762x1024.png 762w, https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-768x1032.png 768w, https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial.png 800w\" sizes=\"(max-width: 223px) 100vw, 223px\" \/><\/a><\/p>\n"},"caption":{"rendered":""},"alt_text":"","media_type":"image","mime_type":"image\/png","media_details":{"width":800,"height":1075,"file":"2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial.png","sizes":{"medium":{"file":"2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-223x300.png","width":223,"height":300,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-223x300.png"},"large":{"file":"2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-762x1024.png","width":762,"height":1024,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-762x1024.png"},"thumbnail":{"file":"2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-150x150.png","width":150,"height":150,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-150x150.png"},"medium_large":{"file":"2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-768x1032.png","width":768,"height":1032,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial-768x1032.png"},"full":{"file":"2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial.png","width":800,"height":1075,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial.png"}},"image_meta":{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0","keywords":[]}},"post":2895,"source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2021-study-of-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-results-of-the-long-term-evaluation-in-the-phase-ii-iii-act-in-sarc-trial.png","_links":{"self":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/media\/2899"}],"collection":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/comments?post=2899"}]}}